Precipio Current Ratio 2010-2024 | PRPO
Precipio current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Precipio Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2024-09-30 |
$0.00B |
$0.00B |
0.73 |
2024-06-30 |
$0.00B |
$0.01B |
0.73 |
2024-03-31 |
$0.00B |
$0.00B |
0.78 |
2023-12-31 |
$0.00B |
$0.00B |
1.17 |
2023-09-30 |
$0.00B |
$0.01B |
0.79 |
2023-06-30 |
$0.00B |
$0.01B |
0.92 |
2023-03-31 |
$0.00B |
$0.01B |
0.89 |
2022-12-31 |
$0.01B |
$0.00B |
1.31 |
2022-09-30 |
$0.01B |
$0.00B |
1.68 |
2022-06-30 |
$0.01B |
$0.00B |
2.19 |
2022-03-31 |
$0.01B |
$0.00B |
2.59 |
2021-12-31 |
$0.01B |
$0.00B |
3.20 |
2021-09-30 |
$0.02B |
$0.00B |
4.14 |
2021-06-30 |
$0.02B |
$0.00B |
4.67 |
2021-03-31 |
$0.00B |
$0.00B |
0.92 |
2020-12-31 |
$0.00B |
$0.01B |
0.90 |
2020-09-30 |
$0.00B |
$0.00B |
0.89 |
2020-06-30 |
$0.00B |
$0.01B |
0.43 |
2020-03-31 |
$0.00B |
$0.01B |
0.25 |
2019-12-31 |
$0.00B |
$0.00B |
0.43 |
2019-09-30 |
$0.00B |
$0.01B |
0.64 |
2019-06-30 |
$0.00B |
$0.01B |
0.49 |
2019-03-31 |
$0.00B |
$0.01B |
0.14 |
2018-12-31 |
$0.00B |
$0.01B |
0.13 |
2018-09-30 |
$0.00B |
$0.01B |
0.14 |
2018-06-30 |
$0.00B |
$0.01B |
0.13 |
2018-03-31 |
$0.00B |
$0.01B |
0.14 |
2017-12-31 |
$0.00B |
$0.01B |
0.17 |
2017-09-30 |
$0.00B |
$0.01B |
0.08 |
2017-06-30 |
$0.00B |
$0.02B |
0.11 |
2017-03-31 |
$0.00B |
$0.02B |
0.03 |
2016-12-31 |
$0.00B |
$0.00B |
0.18 |
2016-09-30 |
$0.00B |
$0.02B |
0.05 |
2016-06-30 |
$0.00B |
$0.02B |
0.10 |
2016-03-31 |
$0.00B |
$0.02B |
0.12 |
2015-12-31 |
$0.00B |
$0.02B |
0.19 |
2015-09-30 |
$0.02B |
$0.02B |
1.00 |
2015-06-30 |
$0.02B |
$0.01B |
1.16 |
2015-03-31 |
$0.02B |
$0.01B |
1.65 |
2014-12-31 |
$0.03B |
$0.01B |
2.38 |
2014-09-30 |
$0.01B |
$0.01B |
1.40 |
2014-06-30 |
$0.01B |
$0.01B |
1.37 |
2014-03-31 |
$0.01B |
$0.01B |
1.58 |
2013-12-31 |
$0.01B |
$0.01B |
1.37 |
2013-09-30 |
$0.01B |
$0.01B |
1.58 |
2013-06-30 |
$0.02B |
$0.01B |
2.52 |
2013-03-31 |
$0.02B |
$0.01B |
2.27 |
2012-12-31 |
$0.02B |
$0.02B |
1.23 |
2012-09-30 |
$0.02B |
$0.02B |
1.36 |
2012-06-30 |
$0.03B |
$0.02B |
1.95 |
2012-03-31 |
$0.03B |
$0.02B |
1.99 |
2011-12-31 |
$0.02B |
$0.02B |
1.05 |
2011-09-30 |
$0.01B |
$0.01B |
1.35 |
2011-06-30 |
$0.01B |
$0.01B |
1.41 |
2011-03-31 |
$0.02B |
$0.01B |
1.76 |
2010-12-31 |
$0.02B |
$0.01B |
1.82 |
2010-09-30 |
$0.01B |
$0.00B |
2.91 |
2010-06-30 |
$0.01B |
$0.00B |
3.06 |
2010-03-31 |
$0.02B |
$0.01B |
3.02 |
2009-12-31 |
$0.01B |
$0.00B |
3.52 |
2009-09-30 |
$0.01B |
$0.00B |
3.71 |
2009-06-30 |
$0.01B |
$0.00B |
3.52 |
2009-03-31 |
$0.02B |
$0.00B |
3.34 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$0.009B |
$0.015B |
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|